NEW YORK – [August 8, 2023] – Neurobit, a global leader in artificial intelligence-driven sleep health analytics, launched Neurobit PSG, an AI-enabled sleep scoring platform that is set to transform the field of sleep analysis. Tailored for healthcare providers, researchers, sleep labs, and enterprises, this advanced solution leverages artificial intelligence algorithms to deliver precise and efficient sleep scoring.

Neurobit PSG stands at the intersection of artificial intelligence and sleep science, introducing an innovative approach to sleep analysis. Built on a clinically validated automated scoring algorithm trained on over a trillion points of demographically diverse multi-channel physiological data, Neurobit PSG simplifies the complex process of sleep evaluation and scoring.

"The development of Neurobit PSG has been driven by the need to address two key challenges in sleep science - efficiency and accuracy," says Dr. Amiya Patanaik, Co-founder of Neurobit. "Our solution delivers on both fronts, providing immediate ROI to registered polysomnographic technologists (RPSGTs), helping to clear backlogs, save valuable time and increase accuracy."

Key features of Neurobit PSG include:

• AI-Powered Sleep Scoring: The software offers accurate and efficient sleep scoring using advanced AI algorithms, helping researchers and healthcare providers to streamline their processes.

• On-Premise Data Security: With an emphasis on maintaining high levels of patient data security, Neurobit PSG can store patient sleep data within the sleep lab's internal system.

• AASM Compliant: Neurobit PSG aligns with American Academy of Sleep Medicine (AASM) guidelines, ensuring standardized and globally recognized sleep scoring.

• Interoperable and Compatible: The solution has been designed to effortlessly integrate with multiple file types and seamlessly fit into existing workflows with zero disruption.

• Total Sleep Time (TST) Accuracy: Neurobit PSG guarantees precise TST measurements, a key feature for home sleep apnea testing (HSAT) devices.

"In an era of qualified staff shortages, solutions that can deliver increased efficiency without compromising accuracy are crucial," adds Kishan, Co-founder of Neurobit. "With Neurobit PSG, we are offering an innovative approach to address this challenge.”

Neurobit PSG also brings a new level of convenience and efficiency with a streamlined process that includes zero-click integration and eradicates any pending scoring or procedural backlogs. It promises clinical-grade accuracy in sleep scoring and ensures high data security with both on-prem and cloud configurations.

To learn more about Neurobit PSG, visit https://www.neurobit.com/psg

About Neurobit

Neurobit is a leading innovator in health analytics, transforming the understanding of sleep as a biomarker to help deliver predictive precision medicine. Their AI-driven solutions offer groundbreaking insights into sleep health and its relation to overall wellbeing. Co-founded by Dr. Amiya Patanaik and Kishan, Neurobit's mission is to revolutionize sleep health and analysis with a range of products for healthcare institutions. With a global footprint, Neurobit operates under the name Neurobit Health from its headquarters in New York, USA, while maintaining presences in Bangalore, India as Neurobit Innovations, and in Singapore as Neurobit Technologies.

Learn more at neurobit.com

Media Contact

Neurobit Press
+1 (929) 214-1342
press@neurobit.com

For downloadable high-resolution logos, product images, and other brand assets, please access our dedicated brand assets page at Neurobit Brand Kit.